Cuspamedical

1 known investors

Cuspa develops a minimally invasive medical device using an artificial cusp that merges with the native aortic valve to treat aortic regurgitation, addressing a gap for patients with moderate to severe AR who lack repair options. The company operates in the medical device sector focused on structural heart and aortic valve disease treatment.